Kligman I, Noyes N, Benadiva C A, Rosenwaks Z
Department of Obstetrics and Gynecology, Cornell University Medical College, New York, New York.
Fertil Steril. 1995 Mar;63(3):673-6. doi: 10.1016/s0015-0282(16)57446-9.
To present the first report of a thromboembolic complication in early pregnancy after ovarian hyperstimulation for IVF in a patient with AT III deficiency who was treated successfully and subsequently delivered a healthy male infant at 32 weeks of gestation.
Case report.
Hospital-based clinic for reproductive medicine.
A 28-year-old woman who consulted our IVF clinic with a 3.5-year history of primary infertility.
Intravenous heparin therapy.
The patient responded adequately to heparin therapy and was discharged home on SC heparin. A primary cesarean section was performed at 32 weeks of gestation because of poor fetal growth and transverse lie.
We stress the importance of obtaining a thorough personal and family history before initiation of ovarian hyperstimulation. Measuring activity of AT III, protein C, and protein S in patients with a suspicious history of thromboembolic episodes occurring at an early age may lead to the implementation of appropriate prophylactic measures, preventing potentially life-threatening complications.
报告首例因体外受精(IVF)进行卵巢过度刺激后早期妊娠发生血栓栓塞并发症的病例,该患者为抗凝血酶III(AT III)缺乏症患者,经成功治疗后于妊娠32周分娩一名健康男婴。
病例报告。
医院生殖医学门诊。
一名28岁女性,因原发性不孕3.5年前来我院IVF门诊就诊。
静脉注射肝素治疗。
患者对肝素治疗反应良好,出院时皮下注射肝素。因胎儿生长受限及横位,于妊娠32周行剖宫产术。
我们强调在开始卵巢过度刺激前获取详尽个人及家族病史的重要性。对有早年血栓栓塞发作可疑病史的患者检测AT III、蛋白C和蛋白S活性,可能会促使实施适当的预防措施,防止潜在的危及生命的并发症。